AV
AVITA Medical, Inc.
AVHHL · OTC
$2.00 +0.00% (+$0.00)
1M +6.38%
Market Cap $248.4M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$1.24
38.0% downside
Current Price
$2
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AVHHL is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
54 /100
Fair P/S 3.28x
EV/EBITDA N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 27.66%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 56.96%
Op. margin 46.57%
FCF margin 31.20%
Quality
21 /100
Poor ROA 90.17%
Asset turnover 1.58x
ROIC 136.99%
Debt
0 /100
High Int. coverage -6.97x
Current ratio 0.41x
Net debt/EBITDA N/A
Stability
32 /100
Unstable Rev. volatility 17.11%
EPS volatility 49.24%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AVHHL
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Cary G. Vance
Employees
226
Headquarters
Valencia
Upcoming events
05 NOV
Earnings
Upcoming earnings report